World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
47
Citations
7758
World Ranking
18723
National Ranking
596

Enzo Bonmassar publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Enzo Bonmassar sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 298 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Enzo Bonmassar D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Enzo Bonmassar sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 47 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Enzo Bonmassar is affiliated with the University of Rome Tor Vergata in Italy. Their research mainly spans the field of Medicine with particular focus on several subfields including Geriatrics and Gerontology, Psychiatry and Mental Health, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging, and Oncology.

The scientist's recent publications highlight investigations into cancer and related biomedical topics. Two notable papers include:

  • Influence of Polydatin on the Tumor Microenvironment In Vitro: Studies with a Colon Cancer Cell Model, 2022, published in International Journal of Molecular Sciences
  • Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?, 2021, published in International Journal of Molecular Sciences

Frequent coauthors collaborating with Bonmassar include Maria Pia Fuggetta, Alex De Gregorio, Ewa K. Krasnowska, Manuela Zonfrillo, and Giampietro Ravagnan. The main venue for their publications is the International Journal of Molecular Sciences.

The scientist's research topics frequently address themes such as:

  • Sirtuins and Resveratrol in Medicine
  • Cancer, Stress, Anesthesia, and Immune Response
  • Nanoplatforms for Cancer Theranostics
  • Effects of Radiation Exposure
  • Cancer Immunotherapy and Biomarkers
  • Childhood Cancer Survivors' Quality of Life

These topics illustrate a multidisciplinary approach combining molecular biology, oncology, and medical technology, with particular attention to cancer biology, immune system responses, and the impact of radiation exposure on health.

Best Publications

  • miR-155 gene: a typical multifunctional microRNA.

    Isabella Faraoni;Francesca Romana Antonetti;John Cardone;Enzo Bonmassar

  • INVOLVEMENT OF THE MISMATCH REPAIR SYSTEM IN TEMOZOLOMIDE-INDUCED APOPTOSIS

    Stefania D’Atri;Lucio Tentori;Pedro Miguel Lacal;Grazia Graziani

  • Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro

    Lorena Rossi;Enzo Bonmassar;Isabella Faraoni

  • DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.

    Simona Caporali;Sabrina Falcinelli;Giuseppe Starace;Maria Teresa Russo

  • Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer Patients

    Pierpaolo Correale;Maria Grazia Cusi;Kwong Yok Tsang;Maria Teresa Del Vecchio

  • Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

    Tiziana Di Pucchio;Lorenzo Pilla;Imerio Capone;Maria Ferrantini

  • Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.

    Giulia Lanzilli;Maria Pia Fuggetta;Maria Tricarico;Andrea Cottarelli

  • Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site.

    Lucio Tentori;Carlo Leonetti;Marco Scarsella;Giulia d'Amati

  • The Effect of O6-Alkylguanine-DNA Alkyltransferase and Mismatch Repair Activities on the Sensitivity of Human Melanoma Cells to Temozolomide, 1,3-bis(2-Chloroethyl)1-nitrosourea, and Cisplatin

    Rita Pepponi;Giancarlo Marra;Maria Pia Fuggetta;Sabrina Falcinelli

  • Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.

    Lauretta Levati;Ester Alvino;Elena Pagani;Diego Arcelli

  • Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.

    M. P. Fuggetta;G. Lanzilli;M. Tricarico;A. Cottarelli

  • MicroRNA‐155 targets the SKI gene in human melanoma cell lines

    Lauretta Levati;Elena Pagani;Sveva Romani;Daniele Castiglia

  • Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.

    I Faraoni;M Turriziani;G Masci;L De Vecchis

  • Antigenic changes of l1210 leukemia in mice treated with 5-(3,3- -dimethyl-1-triazeno)imidazole-4-carboxamide.

    Enzo Bonmassar;Anna Bonmassar;Srikrishna Vadlamudi;Abraham Goldin

  • AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition.

    Simona Caporali;Lauretta Levati;Giuseppe Starace;Gianluca Ragone

  • Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.

    Pierpaolo Correale;Maria Grazia Cusi;Maria Teresa Del Vecchio;Angelo Aquino

  • Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds.

    L Tentori;M Turriziani;D Franco;A Serafino

  • Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A(*)02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro

    Pierpaolo Correale;Angelo Aquino;Anna Giuliani;Monia Pellegrini

  • Drug-induced increase of carcinoembryonic antigen expression in cancer cells.

    Angelo Aquino;Vincenzo Formica;Salvatore Pasquale Prete;Pier Paolo Correale

  • Suppression of Telomerase, Reexpression of KAI1, and Abrogation of Tumorigenicity by Nerve Growth Factor in Prostate Cancer Cell Lines

    Sandra Sigala;Isabella Faraoni;Daniela Botticini;Marcelo Paez-Pereda

Frequent Co-Authors

Maria C. Fioretti
Maria C. Fioretti University of Perugia
Paolo Puccetti
Paolo Puccetti University of Perugia
Carlo Riccardi
Carlo Riccardi University of Perugia
Luigi Frati
Luigi Frati Sapienza University of Rome
Luigina Romani
Luigina Romani University of Perugia
Francesco Bistoni
Francesco Bistoni University of Perugia
Roberta Bianchi
Roberta Bianchi University of Perugia
Josef Jiricny
Josef Jiricny University of Zurich
Giovanna Zambruno
Giovanna Zambruno Bambino Gesù Children's Hospital
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your expertise in Biology and Biochemistry opens doors to a variety of rewarding careers. Today’s online degrees make advanced education in related fields more accessible than ever, helping students to balance studies with work or family commitments.

For those interested in the healthcare industry, online pharmd programs for non pharmacists provide a flexible route to becoming a Doctor of Pharmacy without prior pharmacist credentials. If sports, human movement, or rehabilitation appeal to you, consider a sports science degree online or a kinesiology online degree. These pathways lead to careers in athletics, wellness, physical therapy, and beyond.

Mental health is another fast-growing career area. You can upskill quickly through the fastest pmhnp program to become a Psychiatric Mental Health Nurse Practitioner. Each of these online degree options combines science, technology, and flexible learning to prepare you for high-impact, in-demand roles in today’s job market.

Best Scientists Citing Enzo Bonmassar

Trending Scientists

Recently Published Articles